JNJ vs META: Which Is the Better Buy?
Side-by-side comparison of Johnson & Johnson and Meta Platforms, Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-07-20.
Johnson & Johnson · Healthcare
$253.85
-21.7% upside to fair value
Grade D
High Quality
VS
Meta Platforms, Inc. · Communication Services
$646.01
+43.0% upside to fair value
High Conviction
Grade A
High Quality
QuantHub Verdict
META has more upside to fair value
(+43.0%).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
JNJ |
META |
| Current Price |
$253.85 |
$646.01 |
| Fair Value Estimate |
$198.76 |
$924.09 |
| Upside to Fair Value |
-21.7%
|
+43.0%
|
| Market Cap |
$611.1B |
$1,639.8B |
| Forward P/E |
29.3x
|
—
|
| EV / EBITDA |
19.2x
|
15.0x
|
| Price / Sales |
6.3x
|
7.6x
|
| Price / FCF |
34.3x
|
33.9x
|
| Revenue Growth YoY |
+9.9%
|
+33.1%
|
| Gross Margin |
69.1%
|
81.9%
|
| Operating Margin |
26.9%
|
41.2%
|
| Return on Equity |
26.3%
|
33.2%
|
| Dividend Yield |
0% |
0.33% |
| FCF Yield |
2.91%
|
2.95%
|
| Analyst Consensus |
Buy
|
Strong Buy
|
Investment Thesis
Johnson & Johnson is a leading healthcare conglomerate operating primarily in the drug manufacturing sector, known for its durable competitive moat supported by strong brand recognition and intangible assets. The company exhibits high business quality with a 26.3% return on equity and robust gross and net margins of 69.1% and 21.8%, respectively. However, earnings have faced significant pressure,…
Meta Platforms operates the Facebook, Instagram, Messenger and WhatsApp ecosystem and monetizes its 3.56 billion Family daily active people primarily through digital advertising. Business quality is high: the core platform combines global network effects, advertiser measurement data, creator supply, cross-app distribution and AI-driven ad ranking, supporting 81.9% gross margin, 41.2% operating ma…
Accumulation Zones
| Metric |
JNJ |
META |
| Zone Low |
$149.07 |
$693.07 |
| Zone High |
$168.95 |
$785.48 |
| In Buy Zone? |
No
|
Yes
|